BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Falsey AR. Current management of parainfluenza pneumonitis in immunocompromised patients: a review. Infect Drug Resist 2012;5:121-7. [PMID: 22893749 DOI: 10.2147/IDR.S25874] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Plemper RK. Measles Resurgence and Drug Development. Curr Opin Virol 2020;41:8-17. [PMID: 32247280 DOI: 10.1016/j.coviro.2020.02.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
2 Jones BG, Hayden RT, Hurwitz JL. Inhibition of primary clinical isolates of human parainfluenza virus by DAS181 in cell culture and in a cotton rat model. Antiviral Res 2013;100:562-6. [PMID: 24076357 DOI: 10.1016/j.antiviral.2013.09.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
3 Berrueco R, Antón A, Rives S, Català A, Toll T, Ruiz A, Camós M, Torrebadell M, Estella J, Muñoz-Almagro C. Multiplex real-time PCR for prompt diagnosis of an outbreak of human parainfluenza 3 virus in children with acute leukemia. Infection 2013;41:1171-5. [PMID: 23821486 DOI: 10.1007/s15010-013-0498-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
4 Marcink TC, Porotto M, Moscona A. Parainfluenza virus entry at the onset of infection. Adv Virus Res 2021;111:1-29. [PMID: 34663496 DOI: 10.1016/bs.aivir.2021.07.001] [Reference Citation Analysis]
5 Appelbaum FR, Anasetti C, Antin JH, Atkins H, Davies S, Devine S, Giralt S, Heslop H, Laport G, Lee SJ, Logan B, Pasquini M, Pulsipher M, Stadtmauer E, Wingard JR, Horowitz MM. Blood and marrow transplant clinical trials network state of the Science Symposium 2014. Biol Blood Marrow Transplant 2015;21:202-24. [PMID: 25445636 DOI: 10.1016/j.bbmt.2014.10.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
6 McCarthy MW, Walsh TJ. Prophylactic Measures During Induction for Acute Myeloid Leukemia. Curr Oncol Rep 2017;19:18. [PMID: 28251490 DOI: 10.1007/s11912-017-0574-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
7 Seo S, Xie H, Campbell AP, Kuypers JM, Leisenring WM, Englund JA, Boeckh M. Parainfluenza virus lower respiratory tract disease after hematopoietic cell transplant: viral detection in the lung predicts outcome. Clin Infect Dis 2014;58:1357-68. [PMID: 24599766 DOI: 10.1093/cid/ciu134] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 10.4] [Reference Citation Analysis]
8 von Lilienfeld-Toal M, Berger A, Christopeit M, Hentrich M, Heussel CP, Kalkreuth J, Klein M, Kochanek M, Penack O, Hauf E, Rieger C, Silling G, Vehreschild M, Weber T, Wolf HH, Lehners N, Schalk E, Mayer K. Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology. Eur J Cancer 2016;67:200-12. [PMID: 27681877 DOI: 10.1016/j.ejca.2016.08.015] [Cited by in Crossref: 48] [Cited by in F6Publishing: 30] [Article Influence: 8.0] [Reference Citation Analysis]
9 Godoy C, Peremiquel-Trillas P, Andrés C, Gimferrer L, Uriona SM, Codina MG, Armadans L, Martín Mdel C, Fuentes F, Esperalba J, Campins M, Pumarola T, Antón A. A molecular epidemiological study of human parainfluenza virus type 3 at a tertiary university hospital during 2013-2015 in Catalonia, Spain. Diagn Microbiol Infect Dis 2016;86:153-9. [PMID: 27524509 DOI: 10.1016/j.diagmicrobio.2016.07.023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
10 Raiker NK, Cajigas H. Early initiation of venovenous extracorporeal membrane oxygenation in a mechanically ventilated patient with severe acute respiratory distress syndrome. BMJ Case Rep 2018;2018:bcr-2018-226223. [PMID: 30317205 DOI: 10.1136/bcr-2018-226223] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Cotugno N, Manno EC, Stoppa F, Sinibaldi S, Saffirio C, D'Argenio P, Marano M, Di Nardo M, Palma P. Severe parainfluenza pneumonia in a case of transient hypogammalobulinemia of infancy. BMJ Case Rep 2013;2013:bcr2013009959. [PMID: 23814123 DOI: 10.1136/bcr-2013-009959] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
12 Linfield DT, Raduka A, Aghapour M, Rezaee F. Airway tight junctions as targets of viral infections. Tissue Barriers 2021;9:1883965. [PMID: 33632074 DOI: 10.1080/21688370.2021.1883965] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Harris KM, Horn SE, Grant ML, Lang H, Sani G, Jensen-Wachspress MA, Kankate VV, Datar A, Lazarski CA, Bollard CM, Keller MD. T-Cell Therapeutics Targeting Human Parainfluenza Virus 3 Are Broadly Epitope Specific and Are Cross Reactive With Human Parainfluenza Virus 1. Front Immunol 2020;11:575977. [PMID: 33123159 DOI: 10.3389/fimmu.2020.575977] [Reference Citation Analysis]